Drug Information

Drug General Information
Drug ID
D0S7ZU
Former ID
DNC012634
Drug Name
4-Biphenyl-4-yl-2-methyl-1H-imidazole
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527102]
Formula
C16H14N2
Canonical SMILES
CC1=NC=C(N1)C2=CC=C(C=C2)C3=CC=CC=C3
InChI
1S/C16H14N2/c1-12-17-11-16(18-12)15-9-7-14(8-10-15)13-5-3-2-4-6-13/h2-11H,1H3,(H,17,18)
InChIKey
MBBDOQNKURHTFH-UHFFFAOYSA-N
PubChem Compound ID
44344607
Target and Pathway
Target(s) Sodium channel Target Info Inhibitor [527102]
Voltage-gated sodium channel subunit alpha Nav1.3 Target Info Inhibitor [527102]
KEGG Pathway Dopaminergic synapse
Reactome Interaction between L1 and AnkyrinsR-HSA-445095:Interaction between L1 and Ankyrins
References
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.